Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • NPI Medicare & Medicaid
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.28
    OpenPayerPolicy UpdatesDurable Medical Equipment (DME)BCBS Vermont NMES Coverage & Prior Auth | OpenPaye…
    Ask Trek AI about this page
    CurrentBlue Cross Blue Shield of VermontPolicy 8.03.VT01

    Neuromuscular Electrical Stimulator (NMES) Corporate Medical Policy

    Customize your policy alerts

    Sign up for bcbsvermont Policy 8.03.VT01 alerts

    Get alerted when Policy 8.03.VT01 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Coverage and prior authorization for therapeutic and functional neuromuscular electrical stimulation devices and related services, including medically necessary therapeutic NMES for specified disuse atrophy and investigational functional NMES uses.

    Policy Summary
    PayerBlue Cross Blue Shield of Vermont
    PolicyNeuromuscular Electrical Stimulator (NMES) Corporate Medical Policy
    Policy CodePolicy 8.03.VT01
    Change TypeNo material change
    Effective DateOct 1, 2025
    Last ReviewJun 1, 2025
    Next Review DateJun 1, 2026
    Key ActionObtain prior approval and submit documentation of disuse atrophy, physical examination findings, EMG results, intact nerve supply, and an eligible underlying condition.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    RequiredAuthorization requirement

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    3
    Eligible disuse-atrophy etiologies
    4Investigational functional uses
    12 weeksCasting or splinting threshold
    7Investigational codes

    Coverage Criteria

    Therapeutic NMES medical necessity

    Therapeutic NMES may be considered medically necessary when ALL core requirements and at least ONE eligible clinical indication are met.

    Core requirements

    • Medical necessity and documentation

      • The requested device is therapeutic NMES for the treatment of adequately documented disuse atrophy.
      • The nerve supply to the affected muscle is intact.
      • Clinical improvement may be expected.
      • Disuse atrophy is documented by physical examination and electromyography (EMG).

    • ONE eligible clinical indication

      • Disuse atrophy results from recent hip surgery, until the patient begins physical therapy.
      • Disuse atrophy results from prolonged casting or splinting of a joint.> 12 weeks
      • Contractures result from scarring of soft tissue from burns.
      • The patient has partial paralysis following stroke, and treatment is to improve wrist and finger function and prevent or correct shoulder subluxation.

    Functional NMES investigational uses

    The following functional NMES uses are considered investigational.

    Investigational functional uses

    • Use to provide upper-extremity function in patients with nerve damage, including spinal cord injury or post-stroke nerve damage.
    • Use to improve ambulation in patients with foot drop caused by congenital disorders, such as cerebral palsy, or nerve damage, including post-stroke nerve damage or multiple sclerosis.
    • Use as a technique to provide ambulation in patients with spinal cord injury.
    • Use of exercycles with functional electrical stimulation technology for physical therapy or exercise in patients with spinal cord injury.

    Functional neuromuscular stimulation intended to restore function following nerve damage or nerve injury is excluded from covered medical necessity because it is considered investigational. This includes use to provide upper-extremity function in patients with nerve damage, improve ambulation for foot drop caused by congenital disorders or nerve damage, provide ambulation in patients with spinal cord injury, and use of exercycles with functional electrical stimulation for physical therapy or exercise in patients with spinal cord injury.

    Therapeutic NMES Medical Necessity

    Therapeutic NMES equipment criteria

    Therapeutic NMES equipment may be considered medically necessary when ALL of the following requirements are met.

    • Disuse atrophy is adequately documented by physical examination and electromyography (EMG).
    • The nerve supply to the affected muscle is intact.
    • Clinical improvement is expected.

    • ONE eligible underlying condition or indication

      • Recent hip surgery, until the patient begins physical therapy.

    Documentation Requirements

    Documentation Required

    Document Medical Necessity

    Document medical necessity for therapeutic NMES used to treat adequately documented disuse atrophy. The record must establish the diagnosis by physical examination, include EMG findings, show that nerve supply to the muscle is intact, and identify an eligible underlying condition in which clinical improvement may be expected.

    • Eligible conditions include recent hip surgery until physical therapy begins; prolonged casting or splinting of a joint for more than 12 weeks; contractures caused by burn-related soft-tissue scarring; and treatment to improve wrist and finger function or prevent or correct shoulder subluxation in persons with partial paralysis following stroke.
    • Insufficient medical-necessity documentation may prevent approval or delay the coverage determination.
    • Functional NMES use is investigational and is not covered under the therapeutic NMES criteria.
    Prior Authorization

    Prior Approval and Benefit Verification

    Obtain code-specific prior approval before providing NMES. Submit a complete authorization request containing all information required by the policy guidelines; incomplete requests may delay the decision while missing information is obtained.

    Coding and Code Status

    CPT codes requiring prior approvalCPT
    63650Neurostimulator electrode array, epidural
    63685Insertion or replacement of spinal neurostimulator pulse generator or receiver, direct or inductive coupling
    63688Revision or removal of implanted spinal neurostimulator pulse generator or receiver
    CPT codes requiring prior approvalCPT
    64580Open implantation of neurostimulator electrode array; neuromuscular
    64581Open implantation of neurostimulator electrode array; sacral nerve (transforaminal placement)
    95970Electronic analysis of implanted neurostimulator pulse generator system, without reprogramming
    95971Electronic analysis of implanted neurostimulator pulse generator/transmitter, with intraoperative or subsequent programming; simple spinal cord or peripheral neurostimulator
    HCPCS codes requiring prior approvalHCPCS
    95972Electronic analysis of implanted neurostimulator pulse generator system; complex spinal cord or peripheral neurostimulator pulse generator/transmitter, with intraoperative or subsequent programming, first hour
    A4595Electrical stimulator supplies, 2 lead, per month (e.g., TENS, NMES)
    E0731Form fitting conductive garment for delivery of TENS or NMES
    E0745Neuromuscular stimulator, electronic shock unit
    L8680Implantable neurostimulator electrode, with any number of contact points
    L8682Implantable neurostimulator radiofrequency receiver
    L8686Implantable neurostimulator pulse generator, single array, rechargeable, includes extension
    CPT codesCPT
    64580Open implantation of neurostimulator electrode array; neuromuscular
    64581Open implantation of neurostimulator electrode array; sacral nerve (transforaminal placement)
    95970Electronic analysis of implanted neurostimulator pulse generator system; simple or complex brain, spinal cord, or peripheral neurostimulator pulse generator/transmitter, without reprogramming
    95971Electronic analysis of implanted neurostimulator pulse generator system; simple spinal cord or peripheral neurostimulator pulse generator/transmitter, with intraoperative or subsequent programming
    95972Electronic analysis of implanted neurostimulator pulse generator system; complex spinal cord or peripheral neurostimulator pulse generator/transmitter, with intraoperative or subsequent programming, first hour
    64575Incision for implantation of neurostimulator electrodes; peripheral nerve (excludes sacral nerve)
    64585Revision or removal of peripheral neurostimulator electrodes
    HCPCS codes subject to prior approval where indicatedHCPCS
    A4595Electrical stimulator supplies, 2 lead, per month, (e.g., TENS, NMES)
    E0731Form fitting conductive garment for delivery of TENS or NMES (with conductive fibers separated from the patient's skin by layers of fabric)
    E0745Neuromuscular stimulator, electronic shock unit
    L8680Implantable neurostimulator electrode (with any number of contact points)
    L8682Implantable neurostimulator radiofrequency receiver
    L8686Implantable neurostimulator pulse generator
    L8687Implantable neurostimulator pulse generator, dual array, rechargeable, includes extension
    L8688Implantable neurostimulator pulse generator, dual array, non-rechargeable, includes extension
    L8689External recharging system for battery (internal) for use with implantable neurostimulator, replacement only
    Investigational codesHCPCSExperimental
    A4560Neuromuscular electrical stimulator (NMES), disposable, replacement only
    E0762Transcutaneous electrical joint stimulation device system
    E0764Transcutaneous stimulation of sequential muscle groups of ambulation with computer control, used for walking by spinal cord injured, entire system, after completion of training program
    E0744Neuromuscular stimulator for scoliosis
    E0770Functional electrical stimulator, transcutaneous stimulation of nerve and/or muscle groups, any type, complete system, not otherwise specified
    Prolonged Casting or Splinting
    ConditionProlonged casting or splinting of a joint
    Duration thresholdMore than 12 weeks
    Clinical contextAn eligible indication for therapeutic NMES when clinical improvement may be expected

    Provider Actions and Authorization

    Prior Authorization

    Obtain prior approval

    Prior approval is required for the service before it is provided. Benefits remain subject to all terms, limitations, and conditions of the subscriber contract.

    • Verify coverage under the applicable subscriber contract.
    • Member contract language takes precedence over the medical policy when there is a conflict.
    Prior Authorization

    Check code-specific prior approval

    Review the coding table and obtain prior approval for codes designated “Prior Approval Required.” The requirement applies to the listed CPT and HCPCS codes where indicated.

    • CPT: 63650, 63685, 63688, 64580, 64581, 95970, 95971
    • HCPCS: 95972, A4595, E0731, E0745, L8680, L8682, L8686
    Prior Authorization

    Background

    Neuromuscular electrical stimulators are broadly categorized as therapeutic or functional. Therapeutic stimulation is intended to strengthen muscles weakened by disuse when the nerve supply to the muscle remains intact. Functional stimulation uses electrical stimulation, often with a microprocessor-controlled orthotic device, to assist functional movement by attempting to replace damaged or destroyed nerve pathways.

    Key Definitions

    Therapeutic NMES
    TermTherapeutic NMES
    PurposeElectrical stimulation intended to strengthen muscles weakened by disuse
    Required nerve statusThe nerve supply to the muscle is intact
    Functional NMES
    TermFunctional NMES
    Device approachAn orthotic device with microprocessor-controlled electrical muscular stimulation
    Intended functionAssists functional movement by attempting to replace destroyed nerve pathways

    Not Covered and Investigational Uses

    The following functional NMES uses are not covered because they are considered investigational: providing upper-extremity function for patients with nerve damage; improving ambulation for foot drop caused by congenital disorders or nerve damage; providing ambulation for patients with spinal cord injury; and using exercycles with functional electrical stimulation as physical therapy or exercise for patients with spinal cord injury.

    Policy Summary
    PayerBlue Cross Blue Shield of Vermont
    PolicyNeuromuscular Electrical Stimulator (NMES) Corporate Medical Policy
    Policy CodePolicy 8.03.VT01
    Change TypeNo material change
    Effective DateOct 1, 2025
    Last ReviewJun 1, 2025
    Next Review DateJun 1, 2026
    Key ActionObtain prior approval and submit documentation of disuse atrophy, physical examination findings, EMG results, intact nerve supply, and an eligible underlying condition.
    SourceLink
    On This Page
    Coverage CriteriaTherapeutic NMES Medical NecessityDocumentation RequirementsCoding and Code StatusProvider Actions and AuthorizationBackgroundKey DefinitionsNot Covered and Investigational Uses
    Prolonged casting or splinting of a joint.
    > 12 weeks
  1. Contractures resulting from scarring of soft tissue from burns.
  2. Partial paralysis following stroke requiring treatment to improve wrist and finger function and prevent or correct shoulder subluxation.
    • Verify the member's benefits before providing the service, including applicable exclusions, limitations, contract terms, group or individual benefit documents, and any differences for NEHP/ABNE, FEP, or ASO coverage.
    • Prior approval and benefit availability are subject to the member's subscriber contract; contract language takes precedence over the medical policy when the two conflict.

    Authorize listed NMES codes

    Obtain prior approval for listed procedures, electrical stimulator supplies, conductive garments, neuromuscular stimulators, and implantable neurostimulator components when the coding table identifies the requirement.

    • Procedures: 64580, 95970, 95971, 95972
    • Supplies and garments: A4595, E0731, E0745
    • Implantable components: L8680, L8682, L8686, L8687, L8688, L8689
    Documentation Required

    Document disuse atrophy and EMG findings

    For NMES requested for disuse atrophy, submit medical-record documentation showing disuse atrophy based on physical examination and EMG. The documentation must also identify an eligible underlying condition or post-stroke indication.

    • Show that the nerve supply to the affected muscle is intact.
    • Identify the qualifying etiology, such as recent hip surgery, casting or splinting exceeding 12 weeks, burn-related contractures, or partial paralysis following stroke.
    Documentation Required

    Complete the authorization submission

    Submit complete information required by the policy guidelines with the authorization request. Do not submit the request until the required clinical and supporting information is included.

    • Incomplete requests may delay the decision pending submission of missing information.
    Note

    Verify member benefits

    Verify the member’s applicable contract or benefit plan before providing the service. Coverage, exclusions, limitations, and benefits may vary by group, individual contract, Federal Employee Program coverage, or Administrative Services Only plan.

    • Contact the member’s health plan or customer service department when required.
    • Member contract and employer benefit-plan language takes precedence over the medical policy when there is a conflict.
    Denial Risk

    Identify investigational functional NMES

    Do not represent functional NMES used to restore function following nerve damage or nerve injury as covered medical necessity; these uses are considered investigational.

    • Providing upper-extremity function in patients with nerve damage
    • Improving ambulation for foot drop caused by congenital disorders or nerve damage
    • Providing ambulation in patients with spinal cord injury
    • Using exercycles with functional electrical stimulation for spinal cord injury physical therapy or exercise
    Denial Risk

    Avoid insufficient medical-necessity documentation

    Therapeutic NMES requests may be denied when the record does not document disuse atrophy on physical examination, intact nerve supply, supporting EMG, and an eligible clinical condition.

    • Document disuse atrophy based on physical examination.
    • Include supporting electromyography (EMG).
    • Show intact nerve supply and an eligible etiology or post-stroke indication.
    Denial Risk

    Avoid delays from an incomplete request

    Incomplete prior authorization requests may delay the decision until the missing information is submitted. Ensure the request includes all information required by the policy guidelines.

    • A decision may remain pending while missing information is requested or submitted.
    Billing Rule

    Maintain audit compliance

    Blue Cross VT may audit providers and facilities for compliance with the medical policy. Noncompliance identified during an audit may result in recoupment of all non-compliant payments.

    • Maintain documentation supporting compliance with the policy guidelines.
    • Non-compliant payments identified in an audit may be recouped.
    Denial Risk

    Do not bill investigational codes

    The following codes are identified as investigational and will be denied as investigational.

    • A4560 — Neuromuscular electrical stimulator (NMES), disposable, replacement only
    • E0762 — Transcutaneous electrical joint stimulation device system
    • E0764 — Transcutaneous stimulation of sequential muscle groups for ambulation with computer control
    • E0744 — Neuromuscular stimulator for scoliosis
    • E0770 — Functional electrical stimulator, transcutaneous stimulation of nerve and/or muscle groups, complete system, not otherwise specified
    Disuse Atrophy
    TermDisuse atrophy
    CauseMuscle atrophy resulting from disuse
    Documentation and nerve statusDocumented by physical examination, with intact nerve supply to the affected muscle